Macquarie Group’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-30,000
Closed -$3.19M 1643
2014
Q2
$3.19M Sell
30,000
-7,000
-19% -$687K 0.01% 857
2014
Q1
$3.22M Buy
+37,000
New +$2.86M 0.01% 839

Macquarie Group's FURX Position: Q3 2014 in Review

Macquarie Group sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 30,000 shares — an estimated $3.19M sold.

Macquarie Group first reported a position in FURX in Q1 2014 and held it in 2 quarters. The position peaked at $3.22M in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Macquarie Group reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Macquarie Group sold 30,000 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $3.19M.
  • Macquarie Group first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • Macquarie Group's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $3.22M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Macquarie Group's 13F filing for Q3 2014, filed 14 Nov 2014.